Laurey Mogil, MD
Ophthalmology · Brooklyn, NYNPI 1326049644
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,146 of the $2,986 with a category attached, or 71.9%. 16 manufacturers reported payments, led by Aerie Pharmaceuticals, Inc. at 35.1% of the total. Reporting peaked in 2020 at $1,119 and has fallen 62.9% since, to $415 in 2025.
Across 79 payments — averaging $37.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$1K
- AbbVie$664
- Bausch & Lomb Americas Inc.$235
- Mallinckrodt Hospital Products Inc.$188
- Alcon$157
- Sight Sciences, Inc.$103
- plus $592 from 10 others
What the payments were for
- Consulting fees$82027%
- Food & beverage$2,14672%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 3 | $1,047 |
| AbbVie(2 entities) | 24 | $664 |
| Bausch & Lomb Americas Inc. | 8 | $235 |
| Mallinckrodt Hospital Products Inc. | 7 | $188 |
| Alcon | 7 | $157 |
| Sight Sciences, Inc. | 2 | $103 |
| Biotissue Holdings Inc. | 4 | $90 |
| Sun Pharmaceutical Industries Inc. | 4 | $88 |
| Tarsus Pharmaceuticals, Inc. | 3 | $84 |
| Amgen(2 entities) | 3 | $67 |
| Novartis | 3 | $66 |
| Oyster Point Pharma, Inc. | 4 | $60 |
| Eyevance Pharmaceuticals LLC | 3 | $55 |
| Dompe US, Inc. | 2 | $51 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,986 in reported general payments places this provider in the 65th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Brooklyn
- David RubaltelliBrooklyn$8.9M
- Irene GladsteinBrooklyn$94K
- Nathan RadcliffeNew York$2.1M
- Richard SpaideNew York$1.7M
- Eric DonnenfeldGarden City$1.4M
- Marguerite McDonaldOceanside$893K
- Joshua YoungNew York$814K
- David KleinmanRochester$730K
- Jonathan JonischGreat Neck$726K
- Joseph PanarelliNew York$541K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.